• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Early molecular response is an important prognostic factor for patients with Philadelphia Positive A

Early molecular response is an important prognostic factor for patients with Philadelphia Positive A

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户：liongliong444
【摘 要】
：
Objective Imatinib combined with chemotherapy for induction and intensification therapy has be come the standard strategy for Philadelphia-positive acute lymphocytic leukemia (Ph+ALL).Anyhow,intensifi
【作 者】
：
Pu Kuang Ting Liu Yu Wu Bing Xiang Hongbing Ma Hong Chang Ting Niu Xu Cui Chuang He Jianjun Li Jie Ji Jie Huang Tian Dong Shenglan Qing Huaxin Wu Xiaogong Liang Haiying Guo Chunnong Wu 
【机 构】
：
West China Hospital,Sichuan University People's
【出 处】
：
The 35th World Congress of the International Society of Hema
【发表日期】
：
2014年5期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective Imatinib combined with chemotherapy for induction and intensification therapy has be come the standard strategy for Philadelphia-positive acute lymphocytic leukemia (Ph+ALL).Anyhow,intensified chemotherapy lead to about 5 ％of early death.Because we believed that imatinib plays the most important role in Ph+ALL treatment,we started Ph+ALL-HX-200803 trial to test the effect of combining imatinib and low dose chemotherapy.
其他文献
Rosiglitazone suppresses angiogenesis in multiple myeloma via downregulation of hypoxia inducible fa
Objective s Bone marrow angiogenesis exhibits an important role in multiple myeloma(MM),and angiogenesis often correlates with the prognosis and disease burden of MM.Our previous studies have demonstr
会议
The utility of serum heavy/light chain measurement in the hematological response evaluation of patie
Objective:POEMS syndrome is a rare plasma cell dyscrasia and vascular endothelial growth factor (VEGF),a cytokine correlates with disease activity,is used for disease monitoring.Although clinical impr
会议
Genetic analysis of severe factor XI deficiency in four Chinese patients
Aim Hereditary factor XI deficiency (FXID) is an autosomal inherited coagulation disorder characterized by mild bleeding disorder mainly associated with injury or surgery,which is related to a variety
会议
Relationship between RFC-1 gene polymorphism and methotrexate toxicity in children with acute lympho
Objective:However methotrexate has a remarkable therapeutic effect in childhood ALL,some patients under treatment of this drug manifest complications in various organs.The aim of this study was to eva
会议
Prognostic value of chromosome aberrations by fluorescence in situ hybridization in multiple myeloma
Objective:Genetic characteristics is now considered a standard of care for multiple myeloma (MM) at the time of original diagnosis.Interphase fluorescence in situ hybridization (FISH) has emerged as t
会议
Taliglucerase Alfa in Pediatric Patients with Gaucher Disease: Efficacy, Safety, and Exploratory Gro
Objective:Taliglucerase alfa is a β-glucosidase enzyme replacement therapy approved in the USA and other countries for treatment of Gaucher disease (GD) in adults,and the first approved plant cell-exp
会议
The use of recombinant FXIII in a major acute bleeding episode of a patient with congenital FXIII de
Introduction congenital FXIII deficiency is a rare bleeding disorder with a high risk of spontaneous intracranial haemorrhage.Life-long preventive supplementation is mandatory if FXIII activity is Aim
会议
Genetic Analysis and Th1/Th2 Cytokine Detection in 30 Chinese Children with Familial and non-Familia
Bachground and Objective s Hemophagocytic lymphohistiocytosis (HLH) patients presented a specific cytokine pattern consisting of significantly elevated interferon-gamma (IFN-γ) and interleukin (IL)-10
会议
Enzyme Replacement Therapy With Taliglucerase Alfa: 36-Month Safety and Efficacy Results in Adult Pa
Objective Taliglucerase alfa is the first approved plant cell-expressed recombinant human protein and is an enzyme replacement therapy indicated for treatment of adults with Type 1 Gaucher disease (GD
会议
TREATMENT OF RELAPSED ACUTE LEUKEMIA AFTER ALLO-HSCT BY SALVAGE CHEMOTHERAPY WITH LOW-DOSE CYTARABIN
Background Recurrence is a major cause of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute leukemia,and subsequential treatment options are very limited
会议